Koers Regenicin Inc OTC Bulletin Board
Aandelen
US75887Q1022
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
|
Omzet 2021 | - | Omzet 2022 | - | Marktkapitalisatie | 491K 459K |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | - 0 | Nettowinst (verlies) 2022 | - 0 | EV/omzet 2021 | - |
Nettoschuld 2021 | 598K 559K | Nettoschuld 2022 | 627K 586K | EV/omzet 2022 | - |
K/w-verhouding 2021 |
-2
x | K/w-verhouding 2022 |
-0,71
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 79,1% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Randall McCoy
CEO | Chief Executive Officer | 74 | 15-07-10 |
John Weber
DFI | Director of Finance/CFO | 74 | 13-09-10 |
J. Nelson
CTO | Chief Tech/Sci/R&D Officer | 75 | 15-07-10 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Weber
DFI | Director of Finance/CFO | 74 | 13-09-10 |
Randall McCoy
CEO | Chief Executive Officer | 74 | 15-07-10 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,13% | 122 mld. | |
+19,65% | 115 mld. | |
+21,22% | 26,64 mld. | |
-23,84% | 19,91 mld. | |
-17,47% | 16,32 mld. | |
-45,95% | 15,52 mld. | |
-19,28% | 15,49 mld. | |
+63,81% | 14,83 mld. | |
+1,94% | 13,67 mld. |
- Beurs
- Aandelen
- Koers RGIN
- Koers